2-46581079-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_012249.4(RHOQ):​c.614C>T​(p.Thr205Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,526,116 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

RHOQ
NM_012249.4 missense

Scores

4
11
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.81

Publications

1 publications found
Variant links:
Genes affected
RHOQ (HGNC:17736): (ras homolog family member Q) This gene encodes a member of the Rho family of small GTPases, which cycle between inactive GDP-bound and active GTP-bound states and function as molecular switches in signal transduction cascades. Rho proteins promote reorganization of the actin cytoskeleton and regulate cell shape, attachment, and motility. The encoded protein is an important signalling protein for sarcomere assembly and has been shown to play a significant role in the exocytosis of the solute carrier family 2, facilitated glucose transporter member 4 and other proteins, possibly acting as the signal that turns on the membrane fusion machinery. Three related pseudogene have been identified on chromosomes 2 and 14. [provided by RefSeq, Aug 2011]
PIGF (HGNC:8962): (phosphatidylinositol glycan anchor biosynthesis class F) This gene encodes a protein involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor, a glycolipid containing three mannose molecules in its core backbone, is found on many blood cells where it serves to anchor proteins to the cell surface. The encoded protein and another GPI synthesis protein, PIGO, function in the transfer of ethanolaminephosphate to the third mannose in GPI. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
PIGF Gene-Disease associations (from GenCC):
  • onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RHOQNM_012249.4 linkc.614C>T p.Thr205Met missense_variant Exon 5 of 5 ENST00000238738.9 NP_036381.2 P17081V9HWD0
PIGFNM_002643.4 linkc.*399G>A 3_prime_UTR_variant Exon 6 of 6 ENST00000281382.11 NP_002634.1 Q07326-1Q6IB04

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RHOQENST00000238738.9 linkc.614C>T p.Thr205Met missense_variant Exon 5 of 5 1 NM_012249.4 ENSP00000238738.4 P17081
PIGFENST00000281382.11 linkc.*399G>A 3_prime_UTR_variant Exon 6 of 6 1 NM_002643.4 ENSP00000281382.6 Q07326-1

Frequencies

GnomAD3 genomes
AF:
0.0000266
AC:
4
AN:
150236
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000674
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000149
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000562
AC:
1
AN:
177832
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000115
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000102
AC:
14
AN:
1375762
Hom.:
0
Cov.:
26
AF XY:
0.0000132
AC XY:
9
AN XY:
681018
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29882
American (AMR)
AF:
0.00
AC:
0
AN:
29026
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21184
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38264
South Asian (SAS)
AF:
0.0000278
AC:
2
AN:
71890
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50796
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3776
European-Non Finnish (NFE)
AF:
0.0000102
AC:
11
AN:
1074336
Other (OTH)
AF:
0.0000177
AC:
1
AN:
56608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.407
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000266
AC:
4
AN:
150354
Hom.:
0
Cov.:
32
AF XY:
0.0000409
AC XY:
3
AN XY:
73414
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41442
American (AMR)
AF:
0.0000673
AC:
1
AN:
14856
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3432
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4748
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10370
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.0000149
AC:
1
AN:
67084
Other (OTH)
AF:
0.00
AC:
0
AN:
2076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000302
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00000826
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 12, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.614C>T (p.T205M) alteration is located in exon 5 (coding exon 5) of the RHOQ gene. This alteration results from a C to T substitution at nucleotide position 614, causing the threonine (T) at amino acid position 205 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Uncertain
0.093
D
MetaRNN
Uncertain
0.62
D
MetaSVM
Uncertain
-0.27
T
MutationAssessor
Benign
1.1
L
PhyloP100
7.8
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-1.1
N
REVEL
Uncertain
0.31
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.62
MVP
0.85
MPC
0.99
ClinPred
0.88
D
GERP RS
4.6
Varity_R
0.41
gMVP
0.84
Mutation Taster
=43/57
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141544914; hg19: chr2-46808218; COSMIC: COSV99475681; COSMIC: COSV99475681; API